Dr David Hutchings - Newcells

Retinal platform

An in vitro, light responsive, retinal model for accurate predictions of in vivo outcomes you can have confidence in.

aProximateTM

Kidney platform

The most advanced near-physiological high throughput kidney proximal tubule cells (PTC) model to investigate drug transport modalities in vitro.

Lung epithelia model

Lung model

A model to investigate airway physiology, viral infection, drug safety and environmental impacts on lung airway epithelia.

Sinusoid iPSC-derived Liver model

Liver model

We are developing a model of liver sinusoid derived from human induced pluripotent stem cells (iPSC).

Dr David Hutchings

Chief Commercial Officer

PhD in Biochemistry from University of Manchester.

Over 20 years of experience working in the life science and drug discovery industry, including various commercial roles at PerkinElmer, Discoverx, Qiagen and Axol Bioscience.

Working with customers on: capital equipment – liquid handling automation, robotics, detection instruments (plate readers, nuclear counters); consumables (cell lines, iPSCs, kits, reagents, disposables); service projects (technical solutions for various types of application).

Experience in Europe and North America.

Favourite Quotation: “Take nothing on its looks; take everything on evidence. There’s no better rule.” Charles Dickens in the exchange between Mr Jaggers and Pip in Great Expectations.

Headshot of David Hutchings